John M Burke

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Clostridium Difficile

Newly Diagnosed

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Aaron T Gerds, Ruben Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL. Blood 143 (16) (2024)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
John M Burke, Nicholas Liu, Kristina S Yu, Michelle A Fanale, Andy Surinach, Carlos Flores Avile, Julie Lisano, Tycel Jovelle Phillips
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy. The oncologist (2023)
Aaron T Gerds, Ruben A Mesa, John M Burke, Michael R Grunwald, Brady L Stein, Peg Squier, Jingbo Yu, J E Hamer-Maansson, Stephen T Oh
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: Analysis from REVEAL. Blood (2023)
David Belada, Katerina Kopeckova, Juan-Miguel Bergua, Don Stevens, Marc André, Ernesto Perez Persona, Petra Pichler, Philipp Bernhard Staber, Marek Trněný, Johannes Duell, Maeve Waldron-Lynch, Steve Wagner, Amitava Mukhopadhyay, Maren Dirnberger-Hertweck, John M Burke, Grzegorz S Nowakowski
Safety and efficacy of tafasitamab ± lenalidomide added to first-line R‑CHOP for DLBCL: Phase 1b First-MIND study. Blood (2023)
Alex F Herrera, Manish R Patel, John M Burke, Ranjana Advani, Bruce D Cheson, Jeff P Sharman, Elicia Penuel, Andrew G Polson, Chen Di Liao, Chunze Li, Eva Schuth, Anjali Vaze, Divya Samineni, Rebecca Elstrom, James Cooper, Catherine Diefenbach
Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Anas Younes, John M Burke, Catherine S Diefenbach, Silvia Ferrari, Cyrus Khan, Jeff P Sharman, Monica Tani, Chaitra Ujjani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G Nielsen, Gila Sellam, Michael Gilbertson
Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma. Blood advances 6 (20) (2022)
Anas Younes, John M Burke, Bruce D Cheson, Catherine Diefenbach, Silvia Ferrari, Uwe Hahn, Eliza A Hawkes, Cyrus Khan, Izidore S Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam L S Yuen, Aparna Raval, Mahesh Shivhare, Tina G Nielsen, Gila Sellam, Jeff P Sharman
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma. Blood advances (2022)
Matthew S Davids, Owen A O'Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S Fenske, Pier Luigi Luigi Zinzani, Manish R Patel, Nilanjan Ghosh, Bruce D Cheson, Enrico Derenzini, Danielle M Brander, James A Reeves, Wanda Knopińska-Posłuszny, John N Allan, Tycel Phillips, Paolo F Caimi, Ewa Lech-Maranda, John M Burke, Richy Agajanian, Ruth Pettengell, Lori A Leslie, Chan Yoon Y Cheah, Gustavo Fonseca, James Essell, Julio C Chavez, John M Pagel, Jeff P Sharman, Yanzhi Hsu, Hari P Miskin, Peter Sportelli, Michael S Weiss, Ian W Flinn
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies. Blood advances 5 (23) (2022)
Nathan H Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A Reeves, Wanda Knopińska-Posłuszny, Chan Yoon Y Cheah, Tycel Jovelle Phillips, Ewa Lech-Maranda, Bruce D Cheson, Paolo F Caimi, Sebastian Grosicki, Lori A Leslie, Julio C Chavez, Gustavo Fonseca, Sunil Babu, Daniel James Hodson, Spencer H Shao, John M Burke, Jeff P Sharman, Jennie Y Law, John M Pagel, Hari P Miskin, Peter Sportelli, Owen A O'Connor, Michael S Weiss, Pier Luigi Luigi Zinzani
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Fay J Hlubocky, Anthony L Back, Tait D Shanafelt, Colleen Mary Gallagher, John M Burke, Arif H Kamal, Judith A Paice, Ray D Page, Rebecca Spence, Molly McGinnis, Daniel C McFarland, Piyush Srivastava
Occupational and Personal Consequences of the COVID-19 Pandemic on US Oncologist Burnout and Well-Being: A Study From the ASCO Clinician Well-Being Task Force. JCO oncology practice 17 (7) (2021)